Fairmount Healthcare Fund II L.P., Director, 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN), bought 476,190 shares at $21.00 ($10.0M) on 2024-01-22, disclosed to the SEC on 2024-01-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.